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LETTERS TO THE EDITOR
Reliability of Transfer
Functions in Determining Central
Pulse Pressure and Augmentation Index
We read with interest the study by Wilkinson et al. (1) in the
March 20, 2002, issue of JACC. The investigators employed pulse
wave analysis using sphygmorCor software (AtCor Medical, Syd-
ney, Australia) for the derivation of central aortic waveforms from
radial waveforms acquired by applanation tonometry, and they
presented data on the derived aortic pulse pressure and augmentation
index. The findings of the study are as expected; however, we are
concerned that the technique described is being increasingly utilized,
but remains poorly validated in the literature. The researchers state
that the technique utilizes a “validated transfer function,” yet this
assertion is not supported by the references they quote (2–5).
Karamanoglu et al. (2) derived a transfer function by frequency
domain analysis of central aortic and applanation tonometry-
acquired radial waveforms in 14 patients. They report systolic
pressure alone without prospective validation. Takazawa et al. (4)
applied the transfer function of Karamanoglu et al. (2) to an
additional small cohort and found an 11 mm Hg discrepancy
between measured and derived central aortic pressures, when
tonometry-acquired pressures were calibrated to noninvasive brachial
pressures, suggesting that this transfer function may not be general-
izable to other subjects. These investigators also found the transfer
function to underestimate central augmentation index on average,
with considerable individual variability that was not quantified.
Segers et al. (5) applied the transfer function of Chen et al. (6),
derived by a time domain, rather than a frequency domain,
analysis. There may be important differences between transfer
functions derived by frequency and time domain analyses in their
ability to reconstruct central waveforms accurately, with potential
advantages to the latter (7). Segers et al. (5) found wide individual
variability in derived aortic augmentation index, with Bland-
Altman 95% limits of agreement of approximately 30%. These
findings support those of Fetics et al. (7), using a different transfer
function derived by time domain analysis, who described a per-
centage error in augmentation index estimation of 54  232% in
19 patients, but very good estimation of central systolic pressure,
when tonometry-acquired pressures were calibrated to central
aortic mean and diastolic pressures. These findings are consistent
with the findings of Chen et al. (6) that augmentation index is
highly dependent upon high-frequency components of the wave-
form, and the frequency response characteristics of applanation
tonometry are such that high-frequency data is inevitably lost by
this technique (8). The proprietary transfer function of the
sphygomoCor software is unpublished, and it is unclear as to
whether it has been derived by either frequency or time domain
analysis. Pauca et al. (3) utilized the sphygmoCor software and
prospectively evaluated it for the derivation of central blood pressures
only, from invasively measured radial waveforms, when calibration of
peripheral waveforms was not required. These data cannot validate the
technique for use with noninvasively obtained radial waveforms.
We suggest that, although some transfer functions may ade-
quately reproduce central aortic pressures from radial waveforms
acquired by applanation tonometry, it is premature to suggest that
the technique is well validated for noninvasive use, and published
data suggest that the technique may be unreliable for the derivation
of central aortic augmentation index. This technique should be
properly validated before being applied to large-scale prospective
intervention studies.
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REPLY
We are pleased that Dr. Hope and colleagues enjoyed our study
demonstrating, for the first time, that hypercholesterolemia is
associated with increased central pressure and left ventricular load
(1). We welcome the opportunity to put to bed their previously
voiced concerns regarding the generalized transfer function. In-
deed, new devices and techniques can confuse busy clinicians, and,
therefore, this important issue deserves clarification.
We used a Millar tonometer (SPT-301; Houston, Texas),
identical to that used by one of the investigators in a study
published in the same issue of JACC (2). This device differs from
that used in two of the studies that Dr. Hope and colleagues cite
when questioning the use of a transfer function (references 4 and
8). Moreover, the accuracy of the Millar tonometer has been
confirmed in a series of 62 patients against intra-arterial manom-
eter systems with adequate and known frequency response (3).
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